Open access · OA
via OpenAlex
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie A. Crews, Eliezer Masliah
Human Molecular Genetics · 2010 · ▲ 767 citations
Abstract
Alzheimer's disease (AD) is characterized by cognitive impairment, progressive neurodegeneration and formation of amyloid-beta (Abeta)-containing plaques and neurofibrillary tangles composed of hyperphosphorylated tau. The neurodegenerative process in AD is initially characterized by synaptic damage accompanied by neuronal loss. In addition, recent evidence suggests that alterations in adult neurogenesis in the hippocampus might play a role. Synaptic loss is one of the strongest correlates to the cognitive impairment in patients with AD. Several lines of investigation support the notion that the synaptic pathology and defective neurogenesis in AD are related to progressive accumulation of Abeta oligomers rather than fibrils. Abnormal accumulation of Abeta resulting in the formation of toxic oligomers is the result of an imbalance between the levels of Abeta production, aggregation and clearance. Abeta oligomers might lead to synaptic damage by forming pore-like structures with channel activity; alterations in glutamate receptors; circuitry hyper-excitability; mitochondrial dysfunction(definition); lysosomal failure and alterations in signaling pathways related to synaptic plasticity, neuronal cell and neurogenesis. A number of signaling proteins, including fyn kinase; glycogen synthase kinase-3beta (GSK3beta) and cyclin-dependent kinase-5 (CDK5), are involved in the neurodegenerative progression of AD. Therapies for AD might require the development of anti-aggregation compounds, pro-clearance pathways and blockers of hyperactive signaling pathways.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/ddq160
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Crews, L., & Masliah, E. (2010). Molecular mechanisms of neurodegeneration in Alzheimer's disease. <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/ddq160
Vancouver
Crews L, Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Human Molecular Genetics. 2010. doi:10.1093/hmg/ddq160.
BibTeX
@article{lesliea2010Molecu,
title = {Molecular mechanisms of neurodegeneration in Alzheimer's disease},
author = {Leslie A. Crews and Eliezer Masliah},
journal = {Human Molecular Genetics},
year = {2010},
doi = {10.1093/hmg/ddq160},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Brain Structure and Function 2009
Open access · CC-BY
APP transgenic modeling of Alzheimer’s disease: mechanisms of neurodegeneration and aberrant neurogenesis
Frontiers in Synaptic Neuroscience 2026
Open access · CC-BY
Aging and Alzheimer’s: the critical role of mitochondrial dysfunction and synaptic alterations
Current Protein and Peptide Science 2018
Citation only
Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease
Molecules and Cells 2017
Open access · CC-BY
Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease
Frontiers in Bioscience-Scholar 2012
Open access · OA
The role of mTOR signaling in Alzheimer disease
The HKU Scholars Hub (University of Hong Kong) 2015
Preprint